Strategic rebrand New Century Health has rebranded to Evolent, signaling a broader platform focus beyond specialty care management. This presents an opportunity to approach cross-sell of value-based care solutions, population health, and payer-provider partnerships under the Evolent umbrella.

Expansion potential Recent news indicates Evolent expanding technology and services for oncology with Centene, and partnerships with payers like Florida Blue. Sales opportunities exist in oncology tech-enabled care models, risk-sharing arrangements, and payer-driven benefit designs for complex conditions.

Clinical leadership New chief clinical officers and executives joining Evolent, including hires in 2024–2026, point to a strategic emphasis on clinical governance and population health. This can be leveraged to position advanced clinical solutions, care pathways, and outcomes-focused contracts to health systems and payers.

Technology stack Utilization of Epic Systems, PostgreSQL, Redis, Microsoft Dynamics, ArcGIS and analytics tooling indicates a mature, interoperable tech base. Opportunities exist to integrate or extend with health information exchanges, EHR workflows, and data-driven care management solutions for cardiology and oncology.

Financial and market stance With revenue in the mid-market range and a focus on value-based specialty care, target health plans, large employer groups, and integrated delivery networks seeking cost-effective specialty management, risk-sharing models, and improved outcomes in cardiology and oncology.